hotspot -WSS

hotspot

author：hotspot 2025-09-07 11:17:04 - browse：5949

The Dr. Gary B. and Pamela S. Williams Tower in Summa Health System's Akron Campus — Summa Health

General Catalysts’s grand vision for a venture capital-owned hospital system seamlessly blending AI and tech into everyday appointments and rewarding staff for keeping patients healthy might sound alluring. But the firm’s bold experiment is facing hurdles even before it has started as the community served by the health system it hopes to buy is pushing back.

The Health Assurance Transformation Corp., a General Catalyst entity known as HATCo, unveiled plans last month to acquire Akron safety net provider Summa Health. But since the announcement, residents and local officials have raised questions about who the deal benefits, and who gets left behind.

On Thursday, the Mayor of Akron plans to press HATCo’s chief executive, Marc Harrison, who previously led Intermountain Health, on whether his plan is a profit play or a longer-term investment in the community. At the forefront are citizens’ concerns that the deal will drive up costs, eliminate jobs, reduce the quality of care or even shutter one of just two major hospital systems in the area, about a fifth of whose patients are on Medicaid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Health insurers say they are turning to AI to cut costs, improve care

WSS

How doctors’ personal politics affect patients

Antibiotic resistance nearly killed me, so I'm raising awareness of it

iTeos Therapeutics debuts first data on TIGIT

Former reverend arrested for allegedly killing 8

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

knowledge

hotspot

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Do more moles mean more problems? Not so, says new study

Sports medicine is finally prioritizing gender equality

A new crop of companies is reshaping the health data economy

Heart attack and stroke risk calculators need revising

CDC Director Mandy Cohen on transparency, trust, and health

Duchenne breakthrough therapy leaves behind pioneering families

Antibiotic resistance nearly killed me, so I'm raising awareness of it

After affirmative action ruling, medical educators look to 'holistic review'

Biogen says it will cut costs by $700 million, slash 1,000 jobs

explore

Will the FTC rein in IQVIA's health data empire?

Senate panel puts off hardest PBM reforms for another day

David Sabatini, ex

Dark money group runs ads on China biotech bill

Insmed lung disease drug hits target in key Phase 3 trial

AI used to predict Covid

entertainment

explore

knowledge

focus